Thomas Knittel
Chief Tech/Sci/R&D Officer chez InDex Pharmaceuticals AB
Profil
Thomas Knittel is an Independent Director at HepaRegeniX GmbH and the Chief Medical Officer at InDex Pharmaceuticals AB.
He previously worked as the Director of Business Unit, Sales & Marketing at Novo Nordisk A, Director of Sales & Marketing at Novo Nordisk Pharma GmbH, Vice President of Corporate & Medical Affairs at DeveloGen AG, and General Manager of Pharmaceuticals at Harlan Laboratories, Inc. He also served as the Chief Medical Officer at InDex Pharmaceuticals Holding AB from 2012 to 2022 and was an Associate Professor of Internal Medicine at the University of Gottingen.
Knittel holds a doctorate from the University of Maine and an MBA from Kellogg School of Management.
Postes actifs de Thomas Knittel
| Sociétés | Poste | Début |
|---|---|---|
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Chief Tech/Sci/R&D Officer | 01/01/2012 |
HepaRegeniX GmbH
 HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Director/Board Member | - |
Anciens postes connus de Thomas Knittel
| Sociétés | Poste | Fin |
|---|---|---|
| INDEX PHARMACEUTICALS HOLDING AB | Chief Tech/Sci/R&D Officer | 02/05/2022 |
Harlan Laboratories, Inc.
 Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN. | Corporate Officer/Principal | 01/01/2011 |
| NOVO NORDISK A/S | Sales & Marketing | 01/01/2010 |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Sales & Marketing | 01/01/2010 |
| University of Gottingen | Corporate Officer/Principal | - |
Formation de Thomas Knittel
| University of Maine | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| INDEX PHARMACEUTICALS HOLDING AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
DeveloGen AG
 DeveloGen AG Pharmaceuticals: MajorHealth Technology DeveloGen AG is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders with a particular focus on diabetes. DeveloGen develops highly innovative approaches for the treatment of diabetes and obesity targeting key pathophysiological mechanisms such as insulin resistance and loss of insulin-producing beta cells. DeveloGen's product pipeline includes two programs at advanced stages of lead optimization, a small molecule inhibitor program based on a novel and proprietary target to address insulin resistance (type 2 diabetes). A growth factor targeting beta cell regeneration (type 1 and type 2 diabetes). DeveloGen is based in Goettingen, Germany. | Health Technology |
Harlan Laboratories, Inc.
Harlan Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Harlan Laboratories, Inc. provided essential, pre-clinical and non-clinical contract research, research models, lab animal diets and services. The firm's focused on providing customers with products and services to optimize the discovery and safety of new medicines and compounds. The company was founded in 1931 and was headquartered in Indianapolis, IN. | Commercial Services |
HepaRegeniX GmbH
HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany. | Commercial Services |
InDex Pharmaceuticals AB
InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Health Technology |
